Why Shares of Cassava Sciences Rose 15% Today

Why Shares of Cassava Sciences Rose 15% Today

Source: 
Motley Fool
snippet: 

Shares of Cassava Sciences (NASDAQ:SAVA) -- the biotech company responsible for Alzheimer's drug candidate simufilam -- are up 15% as of Thursday's market close after the company released interim data from a study funded by the National Institutes of Health.